LoginSignup
Hologic logo

Hologic

Stock
Stock
ISIN: US4364401012
Ticker: HOLX
US4364401012
HOLX

Price

Price

CHART BY

Frequently asked questions

What is Hologic's market capitalization?

The market capitalization of Hologic is $16.26B. Market capitalization is a measure of the total market value of a publicly traded company. It is calculated by multiplying the current stock price by the total number of outstanding shares.

What is Hologic's Price-to-Earnings (P/E) ratio?

The Price-to-Earnings (P/E) ratio (TTM) for Hologic is 21.56. This ratio helps investors assess whether a stock is overvalued or undervalued compared to its earnings.

What is the Earnings Per Share (EPS) for Hologic?

Hologic's Earnings Per Share (EPS) over the trailing twelve months (TTM) is $3.321. EPS indicates the company's profitability on a per-share basis.

What are the analyst ratings and target price for Hologic's stock?

Currently, 23 analysts cover Hologic's stock, with a consensus target price of $87.63. Analyst ratings provide insights into the stock's expected performance.

What is Hologic's revenue over the trailing twelve months?

Over the trailing twelve months, Hologic reported a revenue of $4.03B.

What is the EBITDA for Hologic?

Hologic's Earnings before interest, taxes, depreciation, and amortization (EBITDA) over the trailing twelve months is $1.28B. EBITDA measures the company's overall financial performance.

What is the free cash flow of Hologic?

Hologic has a free cash flow of $1.16B. Free cash flow indicates the cash generated after accounting for cash outflows to support operations and capital assets.

How many employees does Hologic have, and what sector and industry does it belong to?

Hologic employs approximately 7,063 people. It operates in the Health Care sector, specifically within the Medical Specialties industry.

What is the free float of Hologic's shares?

The free float of Hologic is 223.70M. Free float refers to the number of shares available for public trading, excluding restricted shares.

Financials

Market Cap 
$16.26B
EPS (TTM) 
$3.321
Free Float 
223.70M
P/E ratio (TTM) 
21.56
Revenue (TTM) 
$4.03B
EBITDA (TTM) 
$1.28B
Free Cashflow (TTM) 
$1.16B

Pricing

52W span
$70.50$84.67

Analyst Ratings

The price target is $87.63 and the stock is covered by 23 analysts.

Buy

9

Hold

13

Sell

1

Information

Hologic, Inc. engages in the development, manufacture, and supply of diagnostics products, medical imaging systems, and surgical products, that focuses on women’s health and well-being through early detection and treatment. It operates through the following segments: Breast Health, Diagnostics, GYN Surgical, and Skeletal Health. The Breast Health segment is involved in a portfolio of solutions for breast cancer care primarily in the areas of radiology, breast surgery, pathology and treatment. The Diagnostics segment offers a range of products, which are used primarily to aid in the screening and diagnosis of human diseases. The GYN Surgical segment is involved in hysteroscopic endometrial ablation systems, tissue removal systems, fluid management systems, and laparoscopic tissue ablation systems and tools. The Skeletal Health segment covers the Horizon DXA and the Fluoroscan Insight FD mini C-arm. The company was founded by S. David Ellenbogen and Jay A. Stein in 1985 and is headquartered in Marlborough, MA.

Employees
7,063
Industries
Medical Specialties
Sector
Health Care

Identifier

ISIN
US4364401012
Primary Ticker
HOLX

Knockouts

Join the conversation
Sign upLogin